Your browser doesn't support javascript.
loading
Genomic Profiling of Premenopausal HR+ and HER2- Metastatic Breast Cancer by Circulating Tumor DNA and Association of Genetic Alterations With Therapeutic Response to Endocrine Therapy and Ribociclib.
Bardia, Aditya; Su, Fei; Solovieff, Nadia; Im, Seock-Ah; Sohn, Joohyuk; Lee, Keun Seok; Campos-Gomez, Saul; Jung, Kyung Hae; Colleoni, Marco; Vázquez, Rafael Villanueva; Franke, Fabio; Hurvitz, Sara; Harbeck, Nadia; Chow, Louis; Taran, Tetiana; Rodriguez Lorenc, Karen; Babbar, Naveen; Tripathy, Debu; Lu, Yen-Shen.
Affiliation
  • Bardia A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.
  • Su F; Novartis Pharmaceuticals Corporation, East Hanover, NJ.
  • Solovieff N; Novartis Pharmaceuticals Corporation, Cambridge, MA.
  • Im SA; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
  • Sohn J; Yonsei Cancer Center, Yonsei University Health System, Seoul, South Korea.
  • Lee KS; Center for Breast Cancer, National Cancer Center, Goyang, South Korea.
  • Campos-Gomez S; Centro Oncológico Estatal, Instituto de Seguridad Social del Estado de México y Municipios, Toluca, Mexico.
  • Jung KH; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Colleoni M; Division of Medical Senology, IEO, European Institute of Oncology, IRCCS, Milan, Italy.
  • Vázquez RV; Institut Català d'Oncologia, Hospital de Sant Joan Despí Moisès Broggi, Barcelona, Spain.
  • Franke F; Hospital de Caridade de Ijuí, CACON, Ijuí, Brazil.
  • Hurvitz S; University of California, Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA.
  • Harbeck N; Department of Obstetrics and Gynecology, Breast Center, Ludwig-Maximilians-University Munich, Munich, Germany.
  • Chow L; Organisation for Oncology and Translational Research, Hong Kong, China.
  • Taran T; Novartis Pharmaceuticals Corporation, East Hanover, NJ.
  • Rodriguez Lorenc K; Novartis Pharmaceuticals Corporation, East Hanover, NJ.
  • Babbar N; Novartis Pharmaceuticals Corporation, Cambridge, MA.
  • Tripathy D; The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Lu YS; National Taiwan University Hospital, Taipei, Taiwan.
JCO Precis Oncol ; 52021.
Article in En | MEDLINE | ID: mdl-34504990
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Purines / Breast Neoplasms / Antineoplastic Agents, Hormonal / Circulating Tumor DNA / Aminopyridines Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Middle aged Language: En Journal: JCO Precis Oncol Year: 2021 Type: Article Affiliation country: Morocco
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Purines / Breast Neoplasms / Antineoplastic Agents, Hormonal / Circulating Tumor DNA / Aminopyridines Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Middle aged Language: En Journal: JCO Precis Oncol Year: 2021 Type: Article Affiliation country: Morocco